Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Maitino

Orthopaedic Surgery Oklahoma City, OK Doctor of Osteopathy

NPI 1376507665 CMS profile 197756

3110 Sw 89Th St, Ste 200 D, Oklahoma City, OK 73159

Open in the dashboard

General payments

$109,744

211 records reported · program years 2019–2025

Research payments

$70,563

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$66,514 paid to institutions, not to them · program years 2020–2024

Through program year 2025, Paul Maitino of Oklahoma City, OK is reported in the CMS Open Payments database as having received $109,744 across 211 general payments and $70,563 in research payments paid to them. Separately, studies naming them as principal investigator received $66,514 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,167 55
2024 General $8,361 14
2023 General $8,359 32
2022 General $9,477 17
2021 General $3,364 22
2020 General $16,125 22
2019 General $57,890 49
2019 Research $70,563 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Maitino
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Paul Maitino were reported at $6,167. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Paul Maitino Orthopaedic Surgery median Middle half National median
2019 $57,890 $644 $140–$2,844 $163
2020 $16,125 $312 $75–$1,860 $114
2021 $3,364 $520 $117–$2,495 $132
2022 $9,477 $598 $128–$2,731 $149
2023 $8,359 $461 $128–$2,264 $160
2024 $8,361 $497 $134–$2,475 $164
2025 $6,167 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lima USA, Inc. $66,623 59 payments
  2. Encore Medical, LP $17,844 15 payments
  3. Stryker Corporation $8,105 32 payments
  4. MicroPort Orthopedics Inc $5,198 8 payments
  5. Limacorporate S.p.A. $2,473 9 payments
  6. Zimmer Biomet Holdings, Inc. $2,454 15 payments
  7. Medical Device Business Services, Inc. $1,980 12 payments
  8. Arthrex, Inc. $1,411 29 payments
  9. Orthalign Inc $1,037 7 payments
  10. Ortho Development Corporation $955 3 payments
  11. Other $1,665 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $64,527 20 payments
  2. Travel and Lodging $38,714 80 payments
  3. Food and Beverage $6,504 111 payments
Products named General payments · program years 2019–2025
  1. Master SL $56,103 44 payments
  2. H-Max $56,083 43 payments
  3. Physica $44,159 39 payments
  4. Delta TT Cups $13,357 7 payments
  5. DJO Surgical TaperFill Hip System $12,200 1 payment
  6. DJO Surgical 3DKnee System $12,200 1 payment
  7. PHYSICA CR $7,487 9 payments
  8. MPO Medial Pivot Knee $5,198 8 payments
  9. DJO SURGICAL $5,015 11 payments
  10. MAKO $4,091 9 payments
  11. Other $31,542 121 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Limacorporate S.p.A. $70,563 6 payments

Prescribing to Medicare patients

Part D · data year 2024 · 39 drugs

Part D claims

4,635

Median for Orthopedic Surgery: 203

Drug cost

$232,732

Median for Orthopedic Surgery: $1,433

Branded share of claims

51.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Belbuca Buprenorphine Hcl Brand 76 $73,990
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 1,351 $48,219
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 597 $25,056
Xtampza Er Oxycodone Myristate Brand 34 $13,989
Buprenorphine Generic 52 $10,757
Oxycodone Hcl Generic 428 $8,922
Oxycontin Oxycodone Hcl Brand 12 $6,875
Fentanyl Generic 66 $6,696
Pregabalin Generic 160 $6,655
Acetaminophen-Codeine Acetaminophen With Codeine Brand 170 $4,770

The 10 drugs with the highest cost, of 39 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$158,070

Of which drugs: $83

Medicare patients

246

Average age 70

Services billed

3,218

154 women, 92 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 36%
Depression 32%
Ischemic heart disease 31%
Chronic kidney disease 23%
COPD 22%
Heart failure 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, ketorolac tromethamine, per 15 mg J1885 Office 36 159 $80
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 24 39 $3

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

217 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record